Total Payments
$3,387
2020 Payments
$295.14
Companies
27
Transactions
264
Medicare Patients
28,810
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$3,387 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,387 | 264 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $888.54 | 52 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $497.89 | 63 | $0 (2019) |
| Novo Nordisk Inc | $354.38 | 28 | $0 (2020) |
| Astellas Pharma US Inc | $261.94 | 14 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $237.21 | 15 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $145.04 | 15 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $124.47 | 9 | $0 (2020) |
| Ironwood Pharmaceuticals, Inc | $107.54 | 10 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $98.62 | 7 | $0 (2020) |
| Lilly USA, LLC | $86.76 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $295.14 | 21 | Novo Nordisk Inc ($82.73) |
| 2019 | $1,380 | 108 | Amgen Inc. ($280.56) |
| 2018 | $651.00 | 57 | Amgen Inc. ($195.51) |
| 2017 | $1,061 | 78 | Amgen Inc. ($354.12) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Bone Health | ||||||
| 03/06/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Neuroscience | ||||||
| 03/03/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes | ||||||
| 02/28/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Neuroscience | ||||||
| 02/27/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Obesity | ||||||
| 02/25/2020 | Hikma Pharmaceuticals USA | Mitigare (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Diabetes | ||||||
| 02/18/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/18/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Central Nervous System | ||||||
| 02/14/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 01/31/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Neuroscience | ||||||
| 01/28/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Obesity | ||||||
| 01/27/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: IMMUNOLOGY | ||||||
| 01/16/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Central Nervous System | ||||||
| 01/14/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Endocrinology | ||||||
| 01/10/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Bone Health | ||||||
| 01/09/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Diabetes | ||||||
| 01/07/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: Central Nervous System | ||||||
| 12/12/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: Central Nervous System | ||||||
| 12/10/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 70 | 7,158 | 25,652 | $1.3M | $387,722 |
| 2022 | 67 | 7,196 | 20,562 | $1.2M | $367,800 |
| 2021 | 63 | 7,568 | 25,642 | $1.3M | $388,691 |
| 2020 | 65 | 6,888 | 20,215 | $1.0M | $326,659 |
Total Patients
28,810
Total Services
92,071
Medicare Billing
$1.5M
Procedure Codes
265
All Medicare Procedures & Services
265 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 515 | 2,058 | $557,718 | $174,963 | 31.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 386 | 386 | $102,412 | $47,735 | 46.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 470 | 1,018 | $59,044 | $16,728 | 28.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 468 | 973 | $69,083 | $12,706 | 18.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 484 | 1,155 | $57,750 | $11,936 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 462 | 1,150 | $12,650 | $9,660 | 76.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 129 | 129 | $10,320 | $9,262 | 89.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 482 | 1,172 | $33,988 | $8,905 | 26.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 52 | 57 | $36,252 | $8,658 | 23.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 36 | 39 | $22,620 | $8,271 | 36.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 92 | $17,572 | $5,642 | 32.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 275 | 549 | $24,156 | $5,208 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 36 | $13,644 | $4,700 | 34.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 404 | 742 | $21,518 | $4,175 | 19.4% |
| 77067 | Screening mammography | Office | 2023 | 32 | 32 | $9,600 | $3,911 | 40.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 133 | 134 | $5,330 | $3,909 | 73.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 404 | 743 | $18,575 | $3,752 | 20.2% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 41 | 86 | $10,234 | $3,308 | 32.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 134 | 134 | $7,370 | $2,535 | 34.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 16 | $6,864 | $2,504 | 36.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 422 | 772 | $13,124 | $2,389 | 18.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 15 | 15 | $11,250 | $2,377 | 21.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,692 | $2,219 | 47.3% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 176 | 279 | $10,323 | $2,186 | 21.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 21 | 23 | $8,786 | $1,977 | 22.5% |
About Dr. Robert Cox, MD
Dr. Robert Cox, MD is a Family Medicine healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164480026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Cox, MD has received a total of $3,387 in payments from pharmaceutical and medical device companies, with $295.14 received in 2020. These payments were reported across 264 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,387).
As a Medicare-enrolled provider, Cox has provided services to 28,810 Medicare beneficiaries, totaling 92,071 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 265 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Greenville, NC
- Active Since 05/02/2006
- Last Updated 10/08/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164480026
Products in Payments
- Prolia (Biological) $427.93
- JANUVIA (Drug) $370.40
- Aimovig (Biological) $237.73
- SYMBICORT (Drug) $188.62
- MYRBETRIQ (Drug) $176.15
- Saxenda (Drug) $147.47
- XIFAXAN (Drug) $132.18
- Repatha (Biological) $124.89
- Ozempic (Drug) $124.41
- AJOVY (Drug) $120.43
- EVENITY (Biological) $97.99
- PNEUMOVAX 23 (Biological) $94.41
- Myrbetriq (Drug) $85.79
- Tresiba (Drug) $82.50
- ZURAMPIC (Drug) $73.74
- SOLIQUA (Drug) $63.58
- INVOKANA (Drug) $61.07
- Livalo (Drug) $54.41
- Synthroid (Drug) $53.63
- Trintellix (Drug) $48.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greenville
James Franklin, M.d, M.D
Family Medicine — Payments: $114,754
Family Medicine $114,754
Jeffrey Harris, Md, MD
Family Medicine — Payments: $112,265
Family Medicine $112,265
Steve Hamberis, M.d, M.D
Family Medicine — Payments: $23,679
Family Medicine $23,679
Dr. Richard Leland, M.d, M.D
Family Medicine — Payments: $22,628
Family Medicine $22,628
Dr. Quentin Mewborn, Md, MD
Family Medicine — Payments: $17,870
Family Medicine $17,870
Eric Faile, M.d, M.D
Family Medicine — Payments: $17,596
Family Medicine $17,596